Role of C807T polymorphism of ITGA2 gene of collagen receptor and platelet aggregation activity in patients with arterial hypertension

Abstract

Aim. To study the prevalence of various C807T polymorphism variants of the ITGA2 gene and to analyze the association of this polymorphism with platelet aggregation activity in hypertensive patients.

Methods. 47 patients with arterial hypertension treated at the Clinical Cardiology Dispensary (Perm) were included in the study. Genotyping of C807T polymorphism (rs 1126643) was carried out by the method of polymerase chain reaction with the subsequent identification of the single nucleotide polymorphic variant of ITGA2 gene by the method of allele-specific polymerase chain reaction. Platelet aggregation activity was investigated by the impedance method using TRAP-6 reagent as an inducer of aggregation.

Results. The prevalence of C/C, C/T, T/T genotypes of ITGA2 gene among hypertensive patients was 18 (38.3%), 23 (48.9%) and 6 (12.8%), respectively. A comparative analysis of platelet aggregation activity with TRAP-6 reagent revealed statistically significant differences between the groups of patients carrying different genotypes [103.5 (67.0; 121.0) AU in homozygotes –807CC versus 52.5 (48; 83) AU in homozygotes –807TT, p=0.045]. In the group of patients with reduced platelet aggregation activity (TRAP-test less than 94 AU), the carriage of the unfavorable T allele prevailed in comparison with the group of patients with its normal level (OR=3.81, 95% CI 1.38–10.54; p=0.008). In patients of this group, there was a significant increase in the frequency of occurrence of heterozygotes –807CT (OR=4.75, 95% CI 1.24–18.19; p=0.009), as well as an increase in the frequency of occurrence of homozygotes for the variant allele -807TT (OR=2.88, 95% CI 0.31–27.07; p=0.009) compared with the group of patients with a normal level of aggregation.

Conclusion. The prevalence of C/C, C/T, T/T genotypes of ITGA2 gene among patients with arterial hypertension is comparable to the data of European researchers: carriers of T allele of ITGA2 gene may have a higher risk of developing cardiovascular events; the molecular mechanism of the relationship of reduced platelet aggregation activity and carriage of the unfavorable T allele of ITGA2 gene requires further studies.

Keywords

arterial hypertension / platelet aggregation activity / ITGA2 gene polymorphism

References

[1] Forouzanfar M.H., Liu P., Roth G.A. et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015. JAMA. 2017; 317 (2): 165–182. DOI: 10.1001/jama.2016.19043.

[2] Forouzanfar M.H., Liu P., Roth G.A. et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017; 317 (2): 165-182. DOI: 10.1001/jama.2016.19043.

[3] Boytsov S.A., Balanova Y.A., Shal’nova S.A. et al. Arterial hypertension among individuals aged 25–64 years: prevalence, awareness, treatment and control. By the data from ECCD. Kardiovaskulyarnaya terapiya i profilaktika. 2014; 13 (4): 414. (In Russ.)

[4] Бойцов С.А., Баланова Ю.А., Шальнова С.А. и др. Артериальная гипертензия среди лиц 25-64 лет: распространённость, осведомлённость, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваск. терап. и профил. 2014; 13 (4): 414. DOI: 10.15829/1728-8800-2014-4-4-14.

[5] Ettehad D., Connor A.E., Kiran A. et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and metaanalysis. Lancet. 2016; 387 (10022): 95767. DOI: 10.1016/S0140-6736(15)01225-8.

[6] Glotov O.S., Baranov V.S Genetic polymorphism, multifactorial diseases and longevity. Meditsinskaya genetika. 2007; (4): 17–29. (In Russ.)

[7] Глотов О.С., Баранов В.С. Генетический полиморфизм, мультифакториальные болезни и долголетие. Мед. генетика. 2007; (4): 17-29.

[8] Sidonets I.V., Meshkov A.N. Genetics for diagnostics in preventive medicine. Kardiovaskulyarnaya terapiya i profilaktika. 2011; 10 (1): 9–13. (In Russ.)

[9] Сидонец И.В., Мешков А.Н. Генетические аспекты диагностики в профилактической медицине. Кардиоваск. терап. и профил. 2014; 13 (4): 75-80. DOI: 10.15829/1728-8800- 2014-4-75-80.

[10] Feng D., Lindpaintner K., Larson M.G. et al. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study. Circulation. 2001; 104 (2): 140–144. DOI: 10.1161/01.CIR.104.2.140.

[11] Feng D., Lindpaintner K., Larson M.G. et al. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study. Circulation. 2001; 104 (2): 140-144. DOI: 10.1161/01.CIR.104.2.140.

[12] Von Beckerath N., Koch W., Mehilli J. et al. Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood. 2000; 95 (11): 3297–3301. PMID: 10828008.

[13] Von Beckerath N., Koch W., Mehilli J. et al. Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood. 2000; 95 (11): 3297-3301. PMID: 10828008.

[14] Liu H., Wang Y., Zheng J. et al. Platelet glycoprotein gene Ia C807T, HPA-3, and Ibα VNTR polymorphisms are associated with increased ischemic stroke risk: Evidence from a comprehensive meta-analysis. Int. J. Stroke. 2017; 12 (1): 46–70. DOI: 10.1177/1747493016672085.

[15] Liu H., Wang Y., Zheng J. et al. Platelet glycoprotein gene Ia C807T, HPA-3, and Ibα VNTR polymorphisms are associated with increased ischemic stroke risk: Evidence from a comprehensive meta-analysis. Int. J. Stroke. 2017; 12 (1): 46-70. DOI: 10.1177/1747493016672085.

[16] Rath D., Schaeffeler E., Winter S. et al. GPIa Polymorphisms are associated with outcomes in patients at high cardiovascular risk. Front. Cardiovasc. Med. 2017; 4: 52. DOI: 10/3389/fcvm.2017.00052.

[17] Chazova I.E., Ratova L.G., Boycov S.A., Nebieridze D.V. Recommendations for the management of arterial hypertension Russian Medical Society of Arterial Hypertension and Society of Cardiology of the Russian Fe­deration. Sistemnye gipertenzii. 2010; (3): 5–26. (In Russ.)

[18] Чазова И.Е., Ратова Л.Г., Бойцов С.А., Небиеридзе Д.В. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов. Системные гипертензии. 2010; (3): 5-26.

[19] Schimmer C., Hamouda K., Sommer S.P. et al. The predictive value of multiple electrode platelet aggregometry (multiplate) in adult cardiac surgery. Thorac. Cardiovasc. Surg. 2013; 61 (8): 733–743. DOI: 10.1055/s-0033-1333659.

[20] Schimmer C., Hamouda K., Sommer S.P. et al. The predictive value of multiple electrode platelet aggregometry (multiplate) in adult cardiac surgery. Thorac. Cardiovasc. Surg. 2013; 61 (8): 733-743. DOI: 10.1055/s-0033-1333659.

[21] Paniccia R., Antonucci E., Maggini N. et al. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery di­sease receiving antiplatelet therapy. Am. J. Clin. Pathol. 2009; 131 (6): 83442. DOI: 10.1309/AJCPTE3K1SGAPOIZ.

[22] Paniccia R., Antonucci E., Maggini N. et al. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy. Am. J. Clin. Pathol. 2009; 131 (6): 83442. DOI: 10.1309/AJCPTE3K1SGAPOIZ.

[23] Villadsen K., Hvas A.-M. Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry. Thromb. Res. 2012; 130 (3): 420–423. DOI: 10.1016/j.thromres.2012.06.017.

[24] Villadsen K., Hvas A.-M. Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry. Thromb. Res. 2012; 130 (3): 420-423. DOI: 10.1016/j.thromres.2012.06.017.

[25] Grinshteyn Yu.I., Kosinova А.А., Grinshteyn I.Yu. et al. Possible genetic predictors of cardiovascular complications after co­ronary bypass. Kardiologiya. 2018; 58 (7): 77–84. (In Russ.)

[26] Гринштейн Ю.И., Косинова А.А., Гринштейн И.Ю. и др. Возможные генетические предикторы развития сердечно-сосудистых осложнений после коронарного шунтирования. Кардиология. 2018; 58 (7): 77-84. DOI: 10.18087/cardio.2018.7.10148.

[27] Leone А., Stefano V., Burzotta F. et al. Glycoprotein Ia C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. Heart. 2004; 90: 567–569. DOI: 10.1136/hrt.2003.017624.

[28] Leone А., Stefano V., Burzotta F. et al. Glycoprotein Ia C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. Heart. 2004; 90: 567-569. DOI: 10.1136/hrt.2003.017624.

[29] Marjoram R.J., Voss B., Pan Y. et al. Suboptimal activation of protease-activated receptors enhances α2β1 integrin-mediated platelet adhesion to collagen. J. Biol. Chem. 2009; 284: 34640. DOI: 10.1074/jbc.M109.020990.

RIGHTS & PERMISSIONS

Shishkina E.A., Khlynova O.V., Vasilets L.M., Sakhena V., Krivtsov A.V.